Anita Singla: Thalassemia Screening in Pregnancy Has a Lifelong Impact
Anita Singla, Senior Consultant – Obstetrics and Gynaecology at Cloudnine Hospital, shared a post on LinkedIn:
“Thalassemia screening in pregnancy is a simple test with a lifelong impact.
Many couples are healthy-looking carriers and may not know it. A CBC with red-cell indices and Hb electrophoresis/HPLC can identify carrier status early. If the mother is a carrier, the father should also be tested.
When both partners are carriers, each pregnancy has a 25% chance of thalassemia major—a condition that may require lifelong blood transfusions and specialised care. Early genetic counselling and prenatal diagnosis help families make informed choices.
Cord blood stem cells may help in selected cases through a matched donor transplant, but cord blood banking is not a substitute for thalassemia screening.
Screen early. Test both partners. Plan a healthier future for your baby.”
Stay updates with Hemostasis Today.
-
Jul 10, 2026, 02:32Nina Laue: Looking Forward to Connecting and Collaborating at ISTH 2026
-
Jul 10, 2026, 02:07Ruman Bashir: Immune Thrombocytopenia in Pregnancy
-
Jul 9, 2026, 19:20Bradley Maron: The Beginning of a New Chapter for Circulation
-
Jul 9, 2026, 19:00Wolfgang Miesbach: ISTH 2026 Showcases the Future of Gene Therapy
-
Jul 9, 2026, 18:21Martin Vanden Eede: Can We Safely Reduce Anticoagulation During ECMO?
-
Jul 9, 2026, 18:00Dorothée Faille: Discovering Versailles During ISTH 2026
-
Jul 9, 2026, 16:45Rutbaa Ayaz Shaikh: One Step Further in Medical Research
-
Jul 9, 2026, 14:49Celebrating a Century of von Willebrand Disease Research and Care – Seminars in Thrombosis and Hemostasis
-
Jul 9, 2026, 14:38Valance Washington: International Hemostasis Community Prepares for GRC 2026